|Bid||7.10 x 4000|
|Ask||7.37 x 2200|
|Day's Range||7.08 - 7.50|
|52 Week Range||2.08 - 8.29|
|Beta (5Y Monthly)||1.42|
|PE Ratio (TTM)||N/A|
|Earnings Date||Feb 25, 2021|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||6.45|
Endo International plc (NASDAQ: ENDP) will announce its fourth-quarter and full-year 2020 financial results on February 25, 2021 after the market closes and members of its senior management team will host a conference call and webcast on February 26, 2021 at 7:30am ET before the U.S. financial markets open.
Does Endo International (ENDP) have what it takes to be a top stock pick for momentum investors? Let's find out.
Radius (RDUS) signs an agreement with Paladin Labs, wherein the latter will now be responsible for all commercial activities related to Tymlos and abaloparatide-TD in Canada.